Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals

If you've ever thought of the mouth as mostly a bacterial story, you're not alone. For years, fungi were the black box of oral ecology—known to be present but hard to see clearly. Then Ghannoum and colleagues stepped in and said, let's map the baseline. Not in disease, not after treatment—just the healthy human mouth, as a reference you can come back to. That move sounds simple, but it's powerful. You can't know what shifts in diabetes or caries or HIV unless you've got a clean snapshot of normal. They built that snapshot with a culture‑independent pipeline that follows a rinse from cup to sequence. Twenty healthy adults in Cleveland, all screened to avoid confounders like recent antifungals or obvious oral disease, swished a standardized oral rinse. The team extracted DNA and focused on the internal transcribed spacer, or ITS, a barcode region that distinguishes fungal taxa. Then they used multitag pyrosequencing—think twenty-four barcoded samples pooled and read on a 454 GS‑FLX—to capture who is there without trying to grow it first. Barcodes let them demultiplex the reads back to each person; blasting those reads against GenBank at a ninety-eight percent identity cutoff gave species-level calls when the data were strong. And they didn't stop at names. They carried the sequences through clustering with CD‑HIT, alignment with KALIGN, trees with PAUP, and then ecological distances with Bray–Curtis and UniFrac, which compares communities using the shape of the phylogenetic tree itself. The upshot: a comprehensive, culture‑independent census of the oral mycobiome. What did that census show? A lot more fungal diversity than most people expect in a healthy mouth. Across the cohort, they counted eighty-five distinct genera—seventy-four that are culturable in the lab and eleven that aren't easily cultured—encompassing one hundred and one species. Non‑culturable organisms weren't a sideshow; they made up thirty-six point one percent of what they detected. At the level of a single person, the mouth carried between nine and twenty-three culturable species, which is a wide spread for a body site we think we know pretty well. You can feel the theme emerging: this is not a narrow cast of characters. Even so, a shared core pops out. Ghannoum's team found a set of fifteen genera that appeared in at least four of the twenty people—a pragmatic definition of "basal" for a first pass. At the front of that pack were Candida, showing up in seventy-five percent of participants, and Cladosporium at sixty-five percent. Two more, Aureobasidium and the yeast-rich order Saccharomycetales, each showed in half the people. A second tier—Aspergillus at thirty-five percent, Fusarium at thirty percent, Cryptococcus at twenty percent—rounded out the familiar names. These are not trivial organisms. Four of those genera include species with real pathogenic potential. The striking part is that they're part of "normal." That tells us right away: context, abundance, and community matter more than presence versus absence. Zoom in one notch to the species level and the community stays textured. Twelve genera had two or more species in the rinse data. Aspergillus led with six, Candida followed with five, then Cladosporium with four, and Fusarium and Penicillium with three each. Within Candida, the usual suspect, Candida albicans, was present in forty percent of subjects. But it didn't have the stage to itself. Non‑albicans species—C. parapsilosis and C. tropicalis at fifteen percent each, C. khmerensis and C. metapsilosis at five percent—were part of the healthy baseline. For clinicians used to equating Candida with disease, that's a humbling recalibration. For microbiologists, it hints that function and interactions—what these fungi are doing alongside bacteria—may be the levers that matter. Now, if there's a basal set, there's also individuality. And here the data are fun. Many genera popped up in only one person—thirty-nine of them, in fact—while just fifteen were shared across at least four individuals. You can see this in extremes. One sample, labeled E3, had only three genera, and nearly two-thirds of its reads were from organisms that we can't currently culture. Another, A2, had sixteen genera, a rich mix that included low but detectable levels of Candida, Dothideomycetes, Xylariales, Fusarium, and Aspergillus. That kind of swing suggests the mouth is open to the environment in more ways than we account for. Spores in the air, food particles, and transient colonizers likely contribute to the long tail of low‑abundance taxa. It's not noise. It's how a boundary organ negotiates the world. The patterns in those long tails also seemed to echo who the participants were. When the team plotted the communities using principal coordinate analysis, a method to map similarity based on Bray–Curtis distance, they saw clusters that lined up with gender and ethnicity. White males tended to group together, Asian males formed a different cluster, and women—Asian and White—clustered with each other rather than with men of their own ethnicity. Visual patterns can be deceiving, so they asked a stricter question with UniFrac, which tests whether two communities are different when you consider how their sequences sit on a phylogenetic tree. On that test, abundance‑weighted and corrected for multiple comparisons, each pairwise comparison among those three classes—females, White males, Asian males—came back with a p-value of 0.03. That's a modest signal, but a consistent one across methods. The authors are appropriately cautious: with only twenty people, you can't cleanly disentangle gender from ethnicity or diet or any number of covariates. Still, the idea that there's a real demographic fingerprint layered on top of a shared core is compelling. Let's loop back for a second to how solid the calls are, because in a first‑of‑its‑kind map, confidence comes from method. The sequencing run produced roughly thirty-nine thousand reads. After barcode sorting and quality control, just over thirty-four thousand reads longer than one hundred bases were analyzed, averaging about one thousand seven hundred reads per person. They matched those reads against GenBank and cross‑checked with curated fungal resources like AFTOL via WASABI, calling species when they hit that ninety-eight percent identity threshold. Those choices cut both ways. They reduce false positives from poor matches, but they also leave some sequences unnamed, reinforcing the point that a significant slice of the oral mycobiome is still off the cultivation and annotation grid. On the ecology side, the mixture of Bray–Curtis—which focuses on compositional differences—and UniFrac—which is rooted in phylogeny—gives a cross‑validation of the signals. Different lenses, same general picture. So what does all this add up to? First, a baseline that says a healthy mouth is home to a fungal community with real breadth—dozens of genera, over one hundred species—where non‑culturable taxa are not rare guests but a third of the room. Second, a core that repeats across people—Candida, Cladosporium, Aureobasidium, Saccharomycetales—cohabiting with genera we usually meet in the clinic, like Aspergillus and Fusarium. Third, individuality that's organized, at least preliminarily, by gender and ethnicity, and likely shaped by environmental exposure. Put together, it moves the field from "we know Candida is around" to "we can quantify a community, and we can ask how it shifts." There are guardrails here, laid out plainly by Ghannoum's team. The cohort is small and local—twenty adults from one metropolitan area, all on a Western diet—so demographic signals are exploratory. The data are cross‑sectional, a single snapshot rather than a movie, which means we can't tell you how stable an individual's profile is week to week. And the ITS‑based, 454 pyrosequencing approach has the biases of its era—primer preferences, read lengths—that newer platforms improve on. None of that undercuts the value of the baseline; it just sets the bounds of what to infer from it. One last thread worth pulling is the coexistence of potential pathogens in health. Candida was present in three out of four people. Aspergillus and Fusarium—names that trigger alarm bells in immunocompromised settings—were not rare. That doesn't mean they're harmless; it means presence isn't destiny. Abundance, community context, and host immunity draw the line between carriage and disease. A baseline like this lets future studies ask sharper questions: when an immunosuppressed patient tips into thrush, which part of the network changed? When a course of antibiotics rearranges the bacteria, do the fungi fill the gap or back off? And if you're wondering where the bacteria fit in this story—good question. This paper didn't profile them, but the authors flag the likely crosstalk. Oral biofilms are mixed neighborhoods. Fungi and bacteria exchange metabolites, oxygen niches, even physical scaffolds. With a fungal baseline in hand, the next step is paired profiles and longitudinal tracking, so we see not just who's there, but how they move together. For now, take the win: as Ghannoum and colleagues showed back in two thousand ten, the healthy human mouth hosts a complex, partly uncultured fungal community with a shared backbone and plenty of personal flair. It's a reference map. The kind you pin to the lab wall and mark up as new data arrive. Because once you can see the baseline clearly, every deviation—by disease, by drug, by diet—starts to mean something.